‘Off-label’ drug use: an FDA regulatory term, not a negative implication of its medical use.

Autor: Meadows, W. A.1, Hollowell, B. D.1 bhollowell@reminger.com
Zdroj: International Journal of Impotence Research. Mar/Apr2008, Vol. 20 Issue 2, p135-144. 10p.
Databáze: Academic Search Ultimate